In dogs, tigilanol tiglate provides a first-line alternative to surgery in non-metastatic mast-cell tumors, meeting an unmet need in the veterinary market. Its launch as Stelfonta in USA ...

Mast cell leukemia (MCL) is a rare type of blood cell cancer. It causes the body to produce a large number of mast cells that can affect different areas of the body. MCL is a subtype of mastocytosis.

Dana-Farber Cancer Institute researchers are breaking ... Systemic mastocytosis (SM) is characterized by an abnormal accumulation of mast cells, a type of immune cell present throughout the ...

Dana-Farber Cancer Institute researchers are breaking ... Systemic mastocytosis (SM) is characterized by an abnormal accumulation of mast cells, a type of immune cell present throughout the ...